Marvell Technology — Sell-Side Analyst Coverage
Ticker: NASDAQ:MRVL · CIK: 0001835632 · Today’s date: 2026-04-29 Stock context: Stock ~$135 (April 28, 2026 close ◐). Median PT $129.09 (TipRanks aggregator); range $85-$156; consensus Strong Buy (23 Buy / 4 Hold / 0 Sell).
This file complements sell side coverage pull (which is the source analyst pull). Here we organize the roster, ratings, thesis shifts, and FY27/FY28 estimate dispersion in a structured analyst-coverage map.
Confidence flags: ✓ verified by primary citation · ◐ widely reported · ⚠ inferred / contested
1. Coverage Roster (30+ Analysts)
Marvell is one of the most widely covered semiconductor names in the US. Below is the major-bank / major-firm roster as identified across TipRanks, MarketBeat, Visible Alpha, and direct analyst note attributions.
Bulge bracket / large-cap banks
| Firm | Analyst | Rating | PT | Last revised | Confidence |
|---|---|---|---|---|---|
| Morgan Stanley | Joseph Moore | Overweight | ~$140 | Apr 2026 ◐ | ✓ analyst named in transcripts |
| Goldman Sachs | Toshiya Hari | Buy | ~$135 | Mar 2026 | ✓ analyst named in transcripts |
| JPMorgan | Harlan Sur | Overweight | $130-$140 | Mar 2026 | ✓ analyst named (Q4 FY25 transcript) |
| Bank of America | Vivek Arya | Buy (upgraded Mar 6 from Neutral) | $110 (raised from $90) | 2026-03-06 | ✓ |
| Citi | Atif Malik | Buy | ~$130 ◐ | Mar 2026 | ✓ analyst named in transcripts |
| Wells Fargo | Aaron Rakers | Overweight | ~$130 ◐ | Mar 2026 | ✓ analyst named in transcripts |
| Barclays | Tom O’Malley | Overweight (upgraded Apr 9 from Equal Weight) | $156 (raised from $105) | 2026-04-09 | ✓ |
| Deutsche Bank | Ross Seymore | Buy | ~$125 ◐ | Mar 2026 | ✓ analyst named in transcripts |
| UBS | Timothy Arcuri | Buy | ~$130 ◐ | Mar 2026 | ✓ analyst named (Q4 FY25 transcript) |
| HSBC | n/a | Buy ◐ | n/a | n/a | ⚠ |
Mid-cap / specialty research
| Firm | Analyst | Rating | PT | Last revised | Confidence |
|---|---|---|---|---|---|
| Stifel | Ruben Roy | Buy → Hold (downgrade Mar 10, 2026, customer-cliff piece) | $115 → $100 ⚠ | 2026-03-10 ◐ | ◐ |
| KeyBanc | John Vinh | Overweight | ~$130 ◐ | Mar 2026 | ✓ analyst named in transcripts |
| Mizuho | Vijay Rakesh | Buy | $125 ◐ | Mar 2026 | ◐ |
| Wedbush | Matt Bryson | Outperform | ~$130 ◐ | Mar 2026 | ◐ |
| Cowen / TD Cowen | Matt Ramsay (had been at Cowen prior to Bernstein move) | Buy ⚠ | n/a | n/a | ⚠ analyst affiliation in flux |
| Susquehanna | Christopher Rolland | Positive | $135 ◐ | Mar 2026 | ✓ analyst named in transcripts |
| Piper Sandler | Harsh Kumar | Overweight ◐ | ~$130 | Mar 2026 | ◐ |
| Loop Capital | Gary Mobley | Buy ◐ | ~$130 | Mar 2026 | ◐ |
| Roth Capital | Suji Desilva | Neutral / Buy ⚠ | $115 ◐ | n/a | ⚠ |
| Needham | Quinn Bolton | Buy | $135 ◐ | Mar 2026 | ◐ |
| Rosenblatt | Hans Mosesmann | Buy | $145 ◐ | Mar 2026 | ◐ |
| Raymond James | Srini Pajjuri | Outperform | $130 ◐ | Mar 2026 | ◐ |
| Bernstein | Stacy Rasgon | Market Perform / Outperform ⚠ | ~$120 | Mar 2026 | ⚠ |
| Truist | William Stein | Buy | ~$135 ◐ | Mar 2026 | ✓ analyst named (Q4 FY25 transcript) |
| Benchmark Co. | Cody Acree (covers communications semis) | Buy (upgraded Mar 6 from Hold; possibly downgraded again Apr 21) | $115 → ~$110 | 2026-04-21 ◐ | ◐ |
| KGI Securities | n/a (Asia-focused) | Outperform (upgraded Mar 6 from Neutral) | ~$125 | 2026-03-06 ◐ | ◐ |
| Evercore ISI | Mark Lipacis | Outperform ◐ | $130 ◐ | Mar 2026 | ◐ |
| Jefferies | Blayne Curtis | Buy ◐ | $130 ◐ | Mar 2026 | ◐ |
| Citizens JMP | n/a | Market Outperform ◐ | $125 ◐ | n/a | ⚠ |
| Oppenheimer | n/a | Outperform ◐ | $125 ◐ | n/a | ⚠ |
Total covering analysts: ~30+ (TipRanks aggregates 27; MarketBeat aggregates 30+; Visible Alpha consensus uses 25-30).
Confidence flag legend: ✓ analyst confirmed by name in transcripts or specific notes; ◐ aggregator-confirmed firm coverage with paraphrased rating/PT; ⚠ inferred or analyst-firm affiliation uncertain.
2. Aggregate Consensus
TipRanks consensus (April 28, 2026)
| Metric | Value | Source confidence |
|---|---|---|
| Consensus rating | Strong Buy | ✓ |
| Buy / Hold / Sell breakdown | 23 / 4 / 0 | ✓ |
| Median price target | $129.09 | ✓ |
| Mean price target | $128.50 | ✓ |
| High PT | $156.00 (Barclays) | ✓ |
| Low PT | $85.00 (bear outlier) | ✓ |
| Implied upside vs. ~$135 stock | -4.4% to +15.6% | ◐ |
12-month PT evolution
| Period | Median PT | Consensus rating | Driver |
|---|---|---|---|
| May 2025 | ~$95 | Buy / Hold mixed | Custom silicon optionality only |
| Sept 2025 | $105-$110 | Buy leaning | Custom + auto divestiture |
| Dec 2025 | $105-$115 | Buy; Benchmark dec downgrade dragged | Custom inflection vs. Amazon loss claim |
| March 2026 (post-Q4 earnings) | $115-$130 | Strong Buy (triple upgrade Mar 6) | $15B FY28 framing; “double” custom |
| April 2026 (post-NVIDIA + Barclays) | $129.09 (median) | Strong Buy | Optical super-cycle thesis crystallized |
3. Notable Thesis Shifts 2024-2026
Shift 1 — December 2024: “Custom silicon executes” (positive)
Catalyst: Q3 FY25 earnings call Dec 3, 2024 — Murphy stated custom silicon was in “high volume production” with “first-pass silicon without any respins.” Stronger-than-forecast custom silicon ramp drove Q3 revenue $66M above midpoint.
Sell-side reaction: Multiple firms raised PT into $90-$110 range. Morgan Stanley, Goldman, JPMorgan all reiterated Buy with upward revisions. Bear narrative (“custom silicon is years away from materiality”) was effectively retired.
Confidence: ✓
Shift 2 — March 5, 2025: “Stock disconnect from fundamentals”
Catalyst: Q4 FY25 earnings beat both revenue and EPS, but stock fell -14.24% on March 6, 2025. Buy-side whisper for Q1 FY26 had been ~$1.95B; management guided ~$1.875B (still +60% YoY).
Sell-side reaction: Defended fundamentals (“the AI thesis is intact; stock reaction is excessive”). Some firms (Bernstein, Stifel) flagged “expectations management” risk.
Confidence: ✓
Shift 3 — December 2025: “Amazon Trainium 3/4 share loss” (Benchmark/Stifel bear thesis)
Catalyst: Mid-December 2025 reports of Amazon allegedly shifting Trainium 3 production share to Alchip (away from Marvell). Benchmark Company downgraded MRVL from Buy to Hold; Stifel later authored a “customer-cliff” piece (March 10, 2026) elaborating the thesis.
Bear thesis components:
- Amazon may be diversifying ASIC supplier base for cost / supply chain reasons.
- If Amazon-Trainium share drops 30-50%, Marvell’s custom silicon revenue would underperform the FY27 +20% target.
- Stifel argued the Q4 FY26 “double in FY28” guidance could compress significantly if customer concentration risk materialized.
Counter-thesis (JPMorgan field research, March 2026):
- Harlan Sur (JPMorgan) conducted primary channel research and concluded “no material loss detected.”
- JPMorgan view: Marvell remains primary partner on Trainium 2 production; Trainium 3 is a multi-supplier program by design (not a binary win/loss).
- Multi-generational program continuity is contractually structured.
Murphy response (Q4 FY26 call, Mar 5, 2026): “Do you see me blinking? You do not.” Reaffirmed multi-generational program continuity without naming customers.
Status: Unresolved at primary-source level (no Amazon/Marvell disclosure resolves it); contested through 2026-Q1 channel checks.
Confidence: ✓ (thesis well-documented); ⚠ (data resolution pending)
Shift 4 — March 6, 2026: Triple upgrade (Bank of America, Benchmark, KGI Securities)
Catalyst: Q4 FY26 earnings beat + explicit FY27 ($11B) and FY28 ($15B) revenue targets + “well over $5” non-GAAP EPS FY28 + “once-in-a-lifetime” framing.
Upgrades:
- Bank of America (Vivek Arya): Neutral → Buy; PT $90 → $110
- Benchmark Company (Cody Acree): Hold → Buy; PT $105 → $115
- KGI Securities (Asia analyst): Neutral → Outperform; PT ~$115 → $125
Implication: Three upgrades in one day, alongside multiple PT raises from existing Buy-rated firms, drove consensus rating to “Strong Buy” and median PT into $115-$130 range.
Confidence: ✓
Shift 5 — March 31 / April 1, 2026: NVIDIA $2B investment
Catalyst: NVIDIA announced $2 billion strategic equity investment in Marvell. Validates Marvell as core infrastructure partner for NVLink Fusion ecosystem.
Sell-side reaction: Multiple firms raised PTs to $130 range; Morgan Stanley reportedly named MRVL “top AI chip pick for 2026.” Wedge between bulls and bears widened.
Confidence: ✓
Shift 6 — April 9, 2026: Barclays Overweight upgrade — “Optical super-cycle”
Catalyst: Barclays analyst Tom O’Malley upgraded MRVL from Equal Weight to Overweight with PT raised from $105 to $156 (now consensus high).
Thesis: Channel checks confirmed optical port count would “double in calendar 2026” and “double again in calendar 2027.” O’Malley reframed optical from a “15% niche CAGR story” to a “20-30% structural CAGR story.”
Quote (paraphrased): “Optical revenue trajectory is now a 20-30% CAGR story, not 15% niche. MRVL is best-positioned optical play.”
Market impact: PT $156 became consensus high; pulled bullish camp aggregate higher. Foreshadowed Polariton acquisition (April 22) which Barclays interpreted as confirmation of the optical-portfolio-build thesis.
Confidence: ✓
Shift 7 — April 21-27, 2026: Valuation downgrades
Catalysts:
- April 21: Benchmark-affiliated note raising Amazon-loss concern again (PT from $115 → ~$110).
- April 27: Seeking Alpha analyst downgrade to Hold (P/E 50x stretched); fair value est. $110-$120.
Bear thesis: Stock has run 50%+ YTD ahead of earnings. P/E of 50-60x with 30% revenue growth is rich vs. semiconductor mean of ~25x. Customer concentration (4 hyperscalers) + Polariton FOMO acquisition timing + cyclical capex cycle risk = correction setup.
Bull counter: Optical super-cycle is structural (Barclays); custom silicon “double in FY28” is contractually backed; NVIDIA $2B is multi-year revenue lock.
Status: Stock fell -3.96% on April 28, 2026 — first significant drawdown signal in months.
Confidence: ✓ (notes published)
Shift 8 — Stifel “customer-cliff” piece (March 10, 2026)
Author: Ruben Roy (Stifel) Date: March 10, 2026 (post-Q4 earnings) Thesis: Despite Q4 beat and “$15B FY28” framing, customer concentration risk is material. Stifel argued that ~70% of custom silicon revenue concentration in 2 customers (Amazon, Microsoft) creates “cliff risk” if either reduces share to alternative ASIC partners (Alchip, GUC, internal teams). PT impact: Reportedly Stifel reduced PT from ~$115 to ~$100 ◐ Status: Outlier bear note within otherwise-bullish March 2026 consensus.
Confidence: ◐ (note exists per sell side coverage pull; specific PT changes from Stifel attributed via aggregator data)
4. Sell-Side Estimate Dispersion (FY27 and FY28)
Management explicitly guided:
- FY27 revenue: ~$11B (+30%+ YoY)
- FY28 revenue: ~$15B (+40% YoY)
- FY28 non-GAAP EPS: “well over $5”
How does the sell-side range cluster?
FY27 revenue estimates (range across covering analysts) ◐
| Quartile | FY27 revenue est | Implied YoY |
|---|---|---|
| Low (bear) | ~$10.0B | +22% |
| Median | ~$11.0B | +34% (in line with guide) |
| High (bull) | ~$11.8B | +44% |
Bear case anchors (Stifel customer-cliff): $10.0-10.3B (assumes Amazon partial loss; FY27 custom silicon +15% rather than +20%) Base case (consensus): $10.8-11.2B (in line with management guide; trusts “at least 20%” custom growth + “40% data center” framing) Bull case (Barclays / Rosenblatt): $11.5-11.8B (assumes optical doubling + custom outperformance from NVIDIA NVLink design wins)
FY28 revenue estimates ◐
| Quartile | FY28 revenue est | vs. mgmt $15B target |
|---|---|---|
| Low (bear) | ~$13.0B | -13% below mgmt |
| Median | ~$14.5B | -3% below mgmt |
| High (bull) | ~$16.0B | +7% above mgmt |
Bear: Customer concentration drag; optical TAM cycle dependency; doesn’t trust “double” custom silicon framing. Base: Trusts management guide directionally; adjusts for execution risk (typical analyst discipline of ~3% below mgmt target). Bull: Optical super-cycle compounds; custom silicon doubles; NVIDIA partnership accretive; Celestial AI ramp adds upside.
FY28 non-GAAP EPS estimates
- Mgmt guide: “well over $5”
- Consensus median ◐: ~$5.40-$5.60
- Bear range: $4.40-$4.80 (assumes margin compression + revenue miss)
- Bull range: $5.80-$6.50 (assumes operating leverage + Celestial AI / NVIDIA upside)
Implication for thesis robustness
The sell-side consensus is closely anchored to management guidance — typical for a momentum AI infrastructure name where management has demonstrated execution credibility (8 consecutive quarters of beats). Estimate dispersion is moderate (~10-15% gap between bear and bull on FY28 revenue), not extreme.
The bear case requires materialization of Amazon Trainium share loss — which requires a multi-quarter unwind that would manifest in Q2-Q3 FY27 custom silicon revenue. Until then, the bear thesis remains a contestable claim, not a refuted one.
5. Beth Kindig & Doug O’Laughlin (Independent Coverage)
Per sell side coverage pull:
- Beth Kindig (I/O Fund / Seeking Alpha “Queen of NVIDIA”): No dedicated MRVL article identified under her byline as of April 2026. Her primary vehicle is NVDA. Recommend checking I/O Fund holdings reports for MRVL position; if held, likely bullish on the optical thesis cascade.
- Doug O’Laughlin (Fabricated Knowledge): Industry-trend coverage rather than equity-specific calls. Substack focus is broader semiconductor cycles; MRVL-specific deep dives are rare.
Confidence: ✓ (per cited search results)
6. Coverage Map Summary Statistics
- Total covering analysts: ~30+
- Buy / Strong Buy: 23
- Hold: 4
- Sell: 0
- Median PT: $129.09 (~consistent with $135 stock = priced at consensus)
- Range: $85 (bear outlier) to $156 (Barclays Overweight)
- Dispersion: Moderate; bear-bull gap ~$30 from median = ~22% range relative to stock price
- Consensus FY27 revenue: ~$11.0B (in line with management $11B guide)
- Consensus FY28 revenue: ~$14.5B (slightly below management $15B; ~3% haircut typical of analyst discipline)
- Consensus FY28 non-GAAP EPS: ~$5.40-$5.60 (slightly below management “well over $5” framing)
Single most contested data point: Whether Amazon Trainium 3/4 share has been retained (JPMorgan: yes; Stifel/Benchmark: contested; resolution requires Q2-Q3 FY27 custom silicon revenue trajectory).
Single most consensus-anchoring data point: Management’s explicit FY28 ~$15B revenue + “well over $5” EPS targets, which most analysts model with a small 3-5% haircut.
7. Tracking Watch List for FY27
Items to monitor for thesis evolution:
- Stifel “customer-cliff” piece (March 10, 2026) — has PT been further revised? Has thesis spread to other firms?
- Q1 FY27 custom silicon revenue (June 2026 earnings) — first material data point on whether 20%+ FY27 growth is realistic.
- Calendar 2026 hyperscaler capex commentary (Microsoft, Amazon, Google, Meta) — feeds into optical port doubling thesis.
- NVLink Fusion adoption metrics post-NVIDIA $2B investment — contracted vs. exploratory revenue.
- Polariton revenue ramp expectations — when does management quantify (likely 2027 investor day or FY28 outlook).
- Amazon disclosures on Trainium silicon partner mix — would resolve the contested Stifel/Benchmark thesis.
Sources
- TipRanks MRVL Forecast: https://www.tipranks.com/stocks/mrvl/forecast
- MarketBeat MRVL Forecast: https://www.marketbeat.com/stocks/NASDAQ/MRVL/forecast/
- Seeking Alpha MRVL: https://seekingalpha.com/symbol/MRVL
- Barclays upgrade (Apr 9, 2026): https://247wallst.com/investing/2026/04/09/barclays-just-raised-marvell-to-overweight-heres-why-the-ai-chip-race-is-far-from-over/
- Marvell Q3 FY25 transcript (analysts named): https://www.fool.com/earnings/call-transcripts/2024/12/03/marvell-technology-mrvl-q3-2025-earnings-call-tran/
- Marvell Q4 FY25 transcript (analysts named): https://www.fool.com/earnings/call-transcripts/2025/03/05/marvell-technology-mrvl-q4-2025-earnings-call-tran/
- Marvell Q4 FY26 transcript: https://www.fool.com/earnings/call-transcripts/2026/03/05/marvell-mrvl-q4-2026-earnings-call-transcript/
- NVIDIA $2B MRVL coverage (April 2026): https://www.fool.com/investing/2026/04/15/the-real-winner-of-nvidias-2-billion-investment-in/
- Marvell Polariton announcement (April 22, 2026): Yahoo Finance via sell side coverage pull
- Seeking Alpha downgrade (April 27, 2026): https://seekingalpha.com/article/4893985-marvell-finally-silences-the-skeptics-but-dont-rush-in-now-downgrade
- Internal: sell side coverage pull (canonical analyst pull)
Cross-links
- comps valuation — comp multiples for valuation framework
- earnings calls — verbatim Q&A attribution to analysts here
- comparable transactions — M&A comps frame strategic-acquirer ceiling
- valuation framework — applies the consensus PT and sell-side estimates
- dsp cannibalization model — Stifel/Benchmark customer-cliff bear thesis interaction
- bear case — sell-side bear narrative consolidated
- bull case — sell-side bull narrative consolidated
- sell side coverage pull — original data pull source
Last updated: 2026-04-29
Cross-references
- Sell-side coverage pull — raw analyst notes / source pulls
- Comps valuation — peer-multiple framework
- Valuation framework — internal valuation lens
- Comparable transactions — M&A comp data
- Guidance revision history